Sunrest Lifescience Ltd IPO

Its registered office and warehouse from where the company operate, are not owned by it.

There are outstanding legal proceedings involving the Company, the Directors and the Promoter.

The company relies on third parties for manufacturing of products for the Company.

The Company requires significant amount of working capital for a continued growth. Its inability to meet the working capital requirements may have an adverse effect on the company results of operations.

The company requires a number of approvals, licences, registrations and permits in the ordinary course of the business and any failure or delay in obtaining the same in a timely manner may adversely affect its operations.

The company's business activities are exposed to fluctuations in the prices of raw materials.

If the company cannot respond adequately to the increased competition its expect to face, the company will lose market share and the profits will decline, which will adversely affect its business, results of operations and financial condition.

There have been instances of delays or non-filling of certain forms which were required to be filed as per the reporting requirements under the Companies Act, 2013 to the Registrar of Companies.

Non generation of separate Unique Document Identification Number (UDIN) for the Tax Audit Report and the Statutory audit Report for the financial year 2019-2020

Non-compliance of Section 203(3) of the Companies Act, 2013.